no more compounding glp 1 drugs Troubling Findings in Study of GLP-1 Compounders GLP-1 Drugs from the Gray

00:23:50 Jennifer Trujillo If somebodys on 3 meds and has a great A1C, that doesnt mean that they 00:23:54 Jennifer Trujillo dont need those meds anymore

Options include increasing concentration, adding microneedling, incorporating other treatments like minoxidil, or switching to GHK-Cu to test whether the alternative copper peptide produces better individual response

Thats everything I tried that didnt work

Understanding your individual peptide sensitivitysuch as variants in the GLP1R genecan help explain how your body responds to each dose

The slowdown came fast, steadily, and relentlessly, as seen in Intuitives subsequent quarterly commentary: Q323: In bariatrics, we continued to see double digit growth albeit at a modestly lower growth rate compared to Q2 Q423: We saw a continued deceleration in growth throughout 2023, likely the result of the uptake of GLP-1 drugs. Q124: Bariatric procedure growth continued to moderate and was flat year-over-year